New Phase Research & Development (Site 181) — Knoxville, Tennessee

New Phase Research & Development (Site 181) is a clinical research site located in Knoxville, Tennessee, United States 37909.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New Phase Research & Development (Site 181) has participated in 1 clinical trials.

Therapeutic areas: Irritable Bowel Syndrome With Diarrhea.

Sponsors: OrphoMed, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Phase Research & Development (Site 181)?

New Phase Research & Development (Site 181) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Phase Research & Development (Site 181) conducted?

New Phase Research & Development (Site 181) has 1 clinical trials on record. Their work covers Irritable Bowel Syndrome With Diarrhea.

Is New Phase Research & Development (Site 181) accredited by Crixeo Health?

New Phase Research & Development (Site 181) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Phase Research & Development (Site 181)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.